Access to the abortion pill mifepristone will remain unchanged until next Wednesday, after a U.S. Supreme Court justice on Friday issued a stay on last week’s ruling from a conservative Texas judge banning the medicine.
Supreme Court Justice Samuel Alito issued an administrative stay preserving access to mifepristone, which has been approved by the Food and Drug Administration since 2000, until 11:59 p.m. ET on Wednesday. It is likely the country’s highest court will rule more substantively on access to the medication before then, a decision that will have major ramifications for the FDA’s authority and access to the commonly used drug.
Alito’s stay comes hours after the Biden administration asked the Supreme Court for an emergency intervention in the wake of clashing rulings from the judge in Texas and another in Washington, who ordered the FDA to ensure access to mifepristone, which is also used to treat miscarriages.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect